KINEPOLIS (KIN.BR) Stock Fundamental Analysis

Europe • Euronext Brussels • EBR:KIN • BE0974274061

27.675 EUR
+0.13 (+0.45%)
Last: Feb 6, 2026, 05:28 PM
Fundamental Rating

4

KIN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 48 industry peers in the Entertainment industry. While KIN is still in line with the averages on profitability rating, there are concerns on its financial health. KIN is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • KIN had positive earnings in the past year.
  • KIN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: KIN reported negative net income in multiple years.
  • Of the past 5 years KIN 4 years had a positive operating cash flow.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • With a decent Return On Assets value of 4.54%, KIN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • KIN has a Return On Equity of 23.61%. This is amongst the best in the industry. KIN outperforms 83.33% of its industry peers.
  • The Return On Invested Capital of KIN (8.28%) is better than 77.08% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for KIN is below the industry average of 9.36%.
  • The last Return On Invested Capital (8.28%) for KIN is above the 3 year average (6.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • With a decent Profit Margin value of 7.98%, KIN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of KIN has declined.
  • With an excellent Operating Margin value of 15.19%, KIN belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
  • KIN's Operating Margin has declined in the last couple of years.
  • KIN has a worse Gross Margin (24.54%) than 83.33% of its industry peers.
  • KIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KIN is creating some value.
  • Compared to 1 year ago, KIN has about the same amount of shares outstanding.
  • KIN has more shares outstanding than it did 5 years ago.
  • KIN has a better debt/assets ratio than last year.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.50, we must say that KIN is in the distress zone and has some risk of bankruptcy.
  • KIN's Altman-Z score of 1.50 is fine compared to the rest of the industry. KIN outperforms 60.42% of its industry peers.
  • KIN has a debt to FCF ratio of 5.38. This is a neutral value as KIN would need 5.38 years to pay back of all of its debts.
  • KIN has a Debt to FCF ratio (5.38) which is in line with its industry peers.
  • KIN has a Debt/Equity ratio of 2.87. This is a high value indicating a heavy dependency on external financing.
  • KIN has a worse Debt to Equity ratio (2.87) than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.5
ROIC/WACC1.4
WACC5.91%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • KIN has a Current Ratio of 0.47. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • KIN's Current ratio of 0.47 is on the low side compared to the rest of the industry. KIN is outperformed by 85.42% of its industry peers.
  • A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
  • The Quick ratio of KIN (0.44) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

  • KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.32%, which is quite impressive.
  • Measured over the past years, KIN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.80% on average per year.
  • Looking at the last year, KIN shows a small growth in Revenue. The Revenue has grown by 5.38% in the last year.
  • Measured over the past years, KIN shows a small growth in Revenue. The Revenue has been growing by 0.95% on average per year.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

  • KIN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.94% yearly.
  • KIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.98% yearly.
EPS Next Y19.98%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
EPS Next 5Y14.94%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

  • KIN is valuated correctly with a Price/Earnings ratio of 16.18.
  • 91.67% of the companies in the same industry are more expensive than KIN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.67. KIN is valued slightly cheaper when compared to this.
  • KIN is valuated reasonably with a Price/Forward Earnings ratio of 10.43.
  • Based on the Price/Forward Earnings ratio, KIN is valued cheaper than 83.33% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. KIN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.18
Fwd PE 10.43
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • KIN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. KIN is cheaper than 68.75% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, KIN is valued cheaper than 85.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.8
EV/EBITDA 8.12
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • KIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as KIN's earnings are expected to grow with 21.15% in the coming years.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y25.83%
EPS Next 3Y21.15%

3

5. Dividend

5.1 Amount

  • KIN has a Yearly Dividend Yield of 1.44%.
  • Compared to an average industry Dividend Yield of 1.06, KIN pays a bit more dividend than its industry peers.
  • Compared to the average S&P500 Dividend Yield of 1.82, KIN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.44%

5.2 History

  • The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 31.09% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP31.09%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (2/6/2026, 5:28:10 PM)

27.675

+0.13 (+0.45%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21
Earnings (Next)02-20
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap757.46M
Revenue(TTM)593.29M
Net Income(TTM)47.32M
Analysts86
Price Target49.3 (78.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.44%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.37%
EPS NY rev (3m)-9.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.14%
Valuation
Industry RankSector Rank
PE 16.18
Fwd PE 10.43
P/S 1.28
P/FCF 5.8
P/OCF 4.37
P/B 3.78
P/tB 33.8
EV/EBITDA 8.12
EPS(TTM)1.71
EY6.18%
EPS(NY)2.65
Fwd EY9.59%
FCF(TTM)4.77
FCFY17.24%
OCF(TTM)6.34
OCFY22.91%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.81
PEG (5Y)N/A
Graham Number16.79
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.5
F-Score8
WACC5.91%
ROIC/WACC1.4
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y19.98%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year104.02%
EBIT Next 3Y35.57%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 4 / 10 to KIN.BR.


Can you provide the valuation status for KINEPOLIS?

ChartMill assigns a valuation rating of 7 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of KINEPOLIS (KIN.BR) stock?

The Price/Earnings (PE) ratio for KINEPOLIS (KIN.BR) is 16.18 and the Price/Book (PB) ratio is 3.78.


Is the dividend of KINEPOLIS sustainable?

The dividend rating of KINEPOLIS (KIN.BR) is 3 / 10 and the dividend payout ratio is 31.09%.